ALNYLAM PHARMACEUTALNYLAM PHARMACEUTALNYLAM PHARMACEUT

ALNYLAM PHARMACEUT

No trades
Buy DUL

DUL fundamentals

An in-depth look to ALNYLAM PHARMACEUT operating, investing, and financing activities

DUL free cash flow for Q2 24 is 104.41 M CHF. For 2023, DUL free cash flow was 35.31 M CHF and operating cash flow was 87.69 M CHF.

Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CHF
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM
Free cash flowYoY growth